CIK: 0001400240 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 2, 2017
Total Value ($000): $283,568 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SERES THERAPEUTICS INC | 12,682,876 | $143,316 | 50.5% | $12.29 | — | COM | 81750R102 |
| — | SYROS PHARMACEUTICALS INC | 4,806,656 | $77,339 | 27.3% | $13.87 | — | COM | 87184Q107 |
| EDIT | EDITAS MEDICINE INC | 3,376,184 | $56,652 | 20.0% | $20.49 | -12.0% | COM | 28106W103 |
| — | T2 BIOSYSTEMS INC | 1,950,583 | $6,261 | 2.2% | $7.24 | — | COM | 89853L104 |